Controlled size and morphology of EDTMP-doped hydroxyapatite nanoparticles as model for 153Samarium-EDTMP doping
- PMID: 18360794
- DOI: 10.1007/s10856-008-3426-1
Controlled size and morphology of EDTMP-doped hydroxyapatite nanoparticles as model for 153Samarium-EDTMP doping
Erratum in
- J Mater Sci Mater Med. 2008 Sep;19(9):3161. Ong, Hooi Tin [added]; Russell, Stephen J [added]; Peng, Kah-Whye [added]
Abstract
Hydroxyapatite (HA) nanoparticles have been studied as nano-sized carriers for the delivery of therapeutic agents. One important consideration for these carriers to be used effectively is their bio-distribution in vivo, of which particle size has a significant effect. In this work, HA nanoparticles doped with Ethylene-diamine-tetramethylene-phosphonate (EDTMP) were synthesized via co-precipitation as a model for HA doped with (153)Samarium ((153)Sm) EDTMP. EDTMP has high affinity for radioactive (153)Sm isotopes that can emit both gamma and beta radiation. The effects of synthesis temperature, amount of dopant and hydrothermal treatment on the size of HA-EDTMP nanoparticles were therefore studied. The results showed that the EDTMP ligand was successfully incorporated in the nanoparticles without changing the crystal structure as shown from X-ray diffractometer (XRD) analysis. From the Field Emission Scanning Electron Microscopy (FESEM) and Transmission Electron Microscopy (TEM) micrographs, it was observed that shorter rod-like nanoparticles, obtained at low synthesis temperatures, became elongated needle-like nanoparticles with increasing temperature. Increasing dopant amount by five fold increases particle size slightly, while a two fold increase in dopant amount has no significant effect. Hydrothermal treatment increases particle crystallinity and results in smooth elongated rod-like structures. The size of HA nanoparticles doped with EDTMP can therefore be manipulated by controlling synthesis temperature and through hydrothermal treatment.
Similar articles
-
Structural Characterization of Sm(III)(EDTMP).Mol Pharm. 2015 Nov 2;12(11):4108-14. doi: 10.1021/acs.molpharmaceut.5b00546. Epub 2015 Oct 14. Mol Pharm. 2015. PMID: 26437889
-
Europium radionuclides in samarium-153-Ethylene Diamine Tetramethylene phosphonic acid (153Sm-EDTMP) radiopharmaceutical waste.Appl Radiat Isot. 2022 Oct;188:110386. doi: 10.1016/j.apradiso.2022.110386. Epub 2022 Jul 31. Appl Radiat Isot. 2022. PMID: 35939938
-
Hydroxyapatite nanocrystals: simple preparation, characterization and formation mechanism.Mater Sci Eng C Mater Biol Appl. 2014 Dec;45:29-36. doi: 10.1016/j.msec.2014.08.058. Epub 2014 Sep 6. Mater Sci Eng C Mater Biol Appl. 2014. PMID: 25491798
-
Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis.Q J Nucl Med. 2001 Mar;45(1):91-9. Q J Nucl Med. 2001. PMID: 11456381 Review.
-
Samarium for osteoblastic bone metastases and osteosarcoma.Expert Opin Pharmacother. 2006 Aug;7(11):1475-86. doi: 10.1517/14656566.7.11.1475. Expert Opin Pharmacother. 2006. PMID: 16859431 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources